がん診断の世界市場分析:タイプ別(臨床検査、遺伝検査、画像検査、内視鏡検査)、用途別(乳房、肺、肝臓、子宮頸、結腸直腸、皮膚)、地域別、セグメント予測、2014 – 2025...市場調査レポートについてご紹介

【英文タイトル】Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of cancer cases
3.2.2 Technological advancement
3.2.3 Initiatives undertaken by government
3.2.4 Reimbursement coverage
3.3 Market Restraints Analysis
3.3.1 Lack of sensitivity and specificity
3.3.2 Risk of high radiation exposure used in different treatments
3.3.3 Cost of diagnosis
3.4 Penetration & growth prospect mapping
3.5 Cancer Diagnostics – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Cancer Diagnostics: Screening Type Estimates & Trend Analysis
4.1 Cancer Diagnostics Market: Screening Type movement analysis
4.1.1. Laboratory Tests
4.1.1.1 Laboratory Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.2 Genetic Tests
4.1.2.1 Genetic Tests Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.3 Imaging
4.1.3.1 Imaging Market Estimates and Forecasts, 2014 – 2025 (USD Billion))
4.1.4 Endoscopy
4.1.4.1 Endoscopy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.5 Biopsy
4.1.5.1 Biopsy Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
4.1.6 Others ( Barium Enema)
4.1.6.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 5 Cancer Diagnostics: Application Estimates & Trend Analysis
5.1 Cancer Diagnostics Market: Application movement analysis
5.1.1 Breast Cancer
5.1.1.1 Breast Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.2 Colorectal Cancer
5.1.2.1 Colorectal Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.3 Cervical Cancer
5.1.3.1 Cervical Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.4 Lung Cancer
5.1.4.1 Lung Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.5 Prostate cancer
5.1.5.1 Prostate Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.6 Skin Cancer
5.1.6.1 Skin Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.7 Blood Cancer
5.1.7.1 Blood Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.8 Kidney Cancer
5.1.8.1 Kidney Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.9 Liver Cancer
5.1.9.1 Liver Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.10 Pancreatic Cancer
5.1.10.1 Pancreatic Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.11 Ovarian Cancer
5.1.11.1 Ovarian Cancer Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
5.1.12 Others
5.1.12.1 Others Market Estimates and Forecasts, 2014 – 2025 (USD Billion)
Chapter 6 Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type
6.1 Cancer Diagnostics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 North America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.2.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3 Europe
6.3.1 Europe Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.3.2 UK
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.4.2 Japan
6.3.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.4.3 China
6.3.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.3.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Market Estimates & forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.5.3.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
6.6 MEA
6.6.1 MEA Cancer Diagnostics Market, 2014 – 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Market Estimates & Forecast, By Screening Type 2014 – 2025 (USD Billion)
6.6.2.2 Market Estimates & Forecast, By Application 2014 – 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Abbott
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Qiagen
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Siemens Healthcare GmbH
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Hologic,Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Koninklijke Philips N.V.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Illumina, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:がん診断の世界市場分析:タイプ別(臨床検査、遺伝検査、画像検査、内視鏡検査)、用途別(乳房、肺、肝臓、子宮頸、結腸直腸、皮膚)、地域別、セグメント予測、2014 – 2025
■ 英文:Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts, 2014-2025
■ 発行日:2017年3月15日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707153
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。